Session 1Friday, 6 April 2018Classification of Lymphoid Malignancy
|
TIME
|
TOPICS
|
SPEAKER
|
|
7.30am to 2pm
|
REGISTRATION
|
|
8.30am to 8.45am
|
Welcome Remarks
|
Dr. Ibrahim Al Hijji
Head of Hematology, NCCCR
Dr. Hareth Al Khater
Deputy Medical Director, NCCCR
|
|
8.45am to 9.30am
|
Classification of Lymphoid Malignancies
|
Dr Adam Bagg
(U. Pennsylvania, USA)
|
|
9.30am to 9.45am
|
Epidemiology of Lymphoid Malignancy in Qatar
|
Dr. Halima El Omri
Dr. Ruba Taha
(NCCCR HMC, Qatar)
|
|
9.45am to 10am |
Diagnostic Genomics & Lymphoid Malignancies
|
Dr. Susanna El Akiki
(HMC, Qatar) |
|
10am to 10.20am |
Coffee Break and Poster Viewing |
|
10.20am to 11am |
Application of Genetic Studies in the Assessment of Aggressive B-cell
Lymphomas |
Dr. Adam Bagg
(U. Pennsylvania, USA) |
|
11am to 11.30am |
Current Approaches in the Treatment of Diffuse Large B Cell Lymphomas |
Prof. Massimo Federico
(U. Modena, Italy) |
|
11.30am to 1.30pm
|
Prayer & Lunch
|
Session 2
|
1.30pm to 1.45pm
|
Double-Expressor Aggressive
B Cell Neoplasms in Qatar
|
Dr. Dina Sameh
Dr. Amna Gamil
Dr. Ruba Taha
(NCCCR, HMC, Qatar)
|
|
1.45pm to 2pm
|
Nervous System Involvement in Lymphomas
|
Dr. Safaa Al Azewi
(NCCCR, HMC, Qatar)
|
|
2pm to 2.30pm
|
Transformed Follicular Lymphoma:
Not All Fit in One
|
Prof. Massimo Federico
(U. Modena, Italy)
|
|
2.30pm to 3pm |
Transplantation for Relapsed and Refractory Hodgkin Lymphoma |
Prof. Stephen Mackinnon
(U. College London, UK) |
|
3pm to 3.20pm |
Coffee Break and Poster Viewing |
|
3.20pm to 3.50pm
|
T Cell Lymphoma: Where we are and where we would like to move forward |
Prof. Massimo Federico
(U. Modena, Italy) |
|
3.50pm to 4.05pm
|
Challenging Case of Gamma Delta T-cell Lymphoma with Precursor T-cells and Marked Eosinophilia
|
Dr. Samah Kohla
Dr. Ahmad Al Sabbagh
(NCCCR, HMC, Qatar)
|
Saturday, 7 April 2018
Session 3
|
8.30am to 9.15am
|
Application of Genetic Studies in the Assessment of Small B-cell Lymphomas
|
Dr. Adam Bagg
(U. Pennsylvania, USA)
|
|
9.15am to 9.45am
|
Therapeutic Approaches
for Patients with CLL
|
Dr. Sylvain Choquet
(H. Pitié-Salpêtrière, France)
|
|
9.45am to 10am
|
Adverse Effects of Target Agents in Indolent Lymphomas
|
Dr. Rola Ghasoub
(NCCCR, HMC, Qatar)
|
|
10am to 10.15am
|
Coffee Break and Poster Viewing
|
|
10:15am to 10.45am
|
Therapeutic Approaches for Patients with Waldenström Macroglobulinemia
|
Dr. Sylvain Choquet
(H. Pitié-Salpêtrière, France)
|
|
10.45am to 11am
|
Clinical and Pathological Profile of Multiple Myeloma in Qatar
|
Dr. Hisham El Sabbah (NCCCR, HMC, Qatar)
|
|
11am to 11.30am
|
Role of PET CT in Lymphoid Malignancies
|
Dr. Zsolt Lengyel
(NCCCR, HMC, Qatar)
|
|
11.30am to 1pm
|
Prayer & Lunch
|
Session 4
|
1pm to 1.30pm
|
CD 19 Chimeric Antigen Receptor
T-Cell Therapy (CAR-T)
|
Dr. Gianfranco Pittari
(NCCCR, HMC, Qatar)
|
|
1.30pm to 2pm
|
Transplantation for Relapsed and Refractory Hodgkin Lymphoma
|
Prof. Stephen Mackinnon
(U. College London, UK)
|
|
2pm to 2.15pm
|
TBI Conditioning in Lymphoid Malignancies
|
Dr. Saju Divakar
(NCCCR, HMC, Qatar)
|
|
2.15pm to 2.30pm
|
PTLD Case Series
|
Dr Afaf Al Battah
Dr Ruba Taha
(NCCCR, HMC, Qatar)
|
|
2.30pm to 2.45pm
|
Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Qatar
|
Dr Afra Fadul
Dr Mohamed Bakr
(NCCCR, HMC, Qatar)
|
|
2.45pm to 3pm
|
Closing Remarks
|
Satellite SymposiaFriday, 6 April 2018
|
1pm to 1.30pm
|
Update on Management of Follicular Lymphoma (ROCHE)
|
Dr. Salem Al Shemmary
(KCC, Kuwait)
|
|
4.15pm to 4.45pm
|
Role of IMIDs in the Management of Multiple Myeloma (Biologix)
|
Prof Mohamed Mohty
(U. Pierre et Marie Curie, France
|
Saturday, 7 April 2018
|
12.30pm to 1pm
|
Immunology-Oncology: An emerging modality in Hodgkin lymphoma treatment (BMS)
|
Dr Ruba Taha
(NCCCR, HMC, Qatar)
|
